PDF(1505 KB)
Expression of β-integrin family members in children with T-cell acute lymphoblastic leukemia
KONG Qing-Lin, AN Xi-Zhou, GUAN Xian-Min, MA Yi-Mei, LI Peng-Fei, LIANG Shao-Yan, HU Yan-Ni, CUI Ying-Hui, YU Jie
Chinese Journal of Contemporary Pediatrics ›› 2017, Vol. 19 ›› Issue (6) : 620-626.
PDF(1505 KB)
PDF(1505 KB)
Expression of β-integrin family members in children with T-cell acute lymphoblastic leukemia
Objective To study the expression of β-integrin family members in children with T-cell acute lymphoblastic leukemia (T-ALL) and their significance. Methods Quantitative real-time PCR analyses were performed to assess the expression levels of β-integrin family members in bone marrow samples from 22 children with newly-diagnosed T-ALL and 21 controls (16 children with non-malignant hematologic disease and 5 healthy donors with bone marrow transplantation). Jurkat cells were treated with integrin inhibitor arginine-glycine-aspartate (Arg-Gly-Asp, RGD) peptide. The cell viability and apoptosis rate were determined by CCK8 assay and flow cytometry respectively. Results The mRNA levels of integrins β2, β3, and β5 were significantly lower in children with T-ALL than in controls (P < 0.05). In T-ALL patients, high integrin β3 expression was associated with lower white blood cell counts (< 100×109/L), minimal residual disease (MRD) positivity, and day 33 bone marrow negative remission (P < 0.05). In T-ALL patients, higher integrin β5 expression was associated with relapse of T-ALL (P < 0.05). Based on survival curve analysis, higher integrin β3 expression was related to lower event-free survival and overall survival rates. RGD peptide treatment inhibited the proliferation of Jurkat cells and increased their apoptosis rate (P < 0.05). Conclusions β-Integrin may play a role in the occurrence and development of T-ALL by affecting cell proliferation and apoptosis. The expression of integrin β5 is closely related to the risk of relapse of T-ALL. The expression of integrin β3 is closely related the treatment response and prognosis of T-ALL.
T-cell acute lymphoblastic leukemia / β-Integrin / Survival analysis / Arginine-glycine-aspartate / Jurkat cell / Child
[1] Durinck K, Goossens S, Peirs S, et al. Novel biological insights in T-cell acute lymphoblastic leukemia[J]. Exp Haematol, 2015, 43(8):625-639.
[2] Cox CV, Martin HM, Keams PR, et al. Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia[J]. Blood, 2007, 109(2):674-682.
[3] Goldberg JM, Silverman LB, Levy DE, et al. Childhood T-cell acute lymphoblastic leukemia:the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience[J]. J Clin Oncol, 2003, 21(19):3616-3622.
[4] Desgrosellier JS, Cheresh DA. Integrins in cancer:biological implications and therapeutic opportunities[J]. Nat Rev Cancer, 2010, 10(1):9-22.
[5] Hynes RO. Integrins:bidirectional, allosteric signaling machines[J]. Cell, 2002, 110(6):673-687.
[6] Kapp TG, Rechenmacher F, Sobahi TR, et al. Integrin modulators:a patent review[J]. Expert Opin Ther Pat, 2013, 23(10):1273-1295.
[7] Lambert AW, Ozturk S, Thiagalingam S. Integrin signaling in mammary epithelial cells and breast cancer[J]. ISRN Oncol, 2012, 2012:493283.
[8] Akkari L, Gocheva V, Kester JC, et al. Distinct functions of macrophage-derived and cancer cell-derived cathepsin Z combine to promote tumor malignancy via interactions with the extracellular matrix[J]. Genes Dev, 2014, 28(19):2134-2150.
[9] 中华医学会儿科学分会血液组, 中华儿科杂志编辑委员会. 儿童急性淋巴细胞白血病诊疗建议(第三次修订草案)[J]. 中华儿科杂志, 2006, 44(5):392-395.
[10] 孙伊娜, 柴忆欢, 何海龙, 等. CCLG-ALL2008方案治疗儿童急性淋巴细胞性白血病的临床疗效[J]. 江苏医药, 2011, 24(37):2922-2925.
[11] 秘营昌, 卞寿庚. 急性白血病[M]//张之南, 沈悌. 血液病诊断及疗效标准. 第3版. 北京:科学出版社, 2007:131-134.
[12] Kapp TG, Rechenmacher F, Sobahi TR, et al. Integrin modulators:a patent review[J]. Expert Opin Ther Pat, 2013, 23(10):1273-1295.
[13] Roth P, Silginer M, Goodman SL, et al. Integrin control of the transforming growth factor-β pathway in glioblastoma[J]. Brain, 2013, 136(Pt 2):564-576.
[14] 王耀平. 儿童及少年急性淋巴细胞白血病危险因素评估[J]. 白血病.淋巴瘤, 2005, 14(4):241-242.
[15] 王跃平. 儿童急性白血病诊治进展[J]. 实用医院临床杂志, 2007, 4(6):33-38.
[16] Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia[J]. Lancet, 2008, 371(9617):1030-1043.
[17] 管箫玉, 李庆伟, 王继红. RGD肽抗肿瘤机制及进展[J].吉林医药学院学报, 2015, 36(5):361-365.
[18] 沈瑛, 糜军. 靶向整合素αVβ3的分子影像探针[J].中国癌症杂志, 2010, 20(4):303-307.
